-Rediff.com Born in Mumbai's infamous red-light district, Shweta Katti has won a scholarship to the Bard College, New York. This is her story. Shweta Katti is warming up to the media attention she's been receiving lately. She has had a long day but has agreed to meet me at a coffee shop for what must have been the nth interview she's giving in the last 48 hours. It is close to 10 in...
More »SEARCH RESULT
Total Matching Records found : 725
Wireless messages dent SIT claim on Modi-Vidya Subrahmaniam
-The Hindu Extracts show violence before and during funeral processions of kar sevaks In its closure report submitted to the trial court, the Special Investigation Team that probed Zakia Jafri's complaintagainst Narendra Modi and 58 others said there was no evidence to prove that the Chief Minister had sent the bodies of the 2002 Godhra victims to Ahmedabad with a view to parading them before the public. The SIT quoted Ahmedabad Police Commissioner...
More »Doublespeak on electoral reforms-N Gopalaswami
-The Hindu The paid news case is no longer just about Ashok Chavan. It concerns every individual and institution opposed to the sway of money power in elections Politicians everywhere are known to indulge in doublespeak and our politicians are no exception. But some recent pronouncements of our Law Minister only show that our politicians may have very few serious rivals in this sport. Not long ago, the Minister was all praise...
More »Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »
